Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Clinical inquiries: Do glucosamine and chondroitin worsen blood sugar control in diabetes?
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 7502590 Publication Model: Print Cited Medium: Print ISSN: 0094-3509 (Print) Linking ISSN: 00943509 NLM ISO Abbreviation: J Fam Pract Subsets: MEDLINE
- Publication Information:
Publication: Parsippany, NJ : Frontline Medical Communications
Original Publication: New York, Appleton-Century-Crofts.
- Subject Terms:
- Abstract:
Despite theoretical risks based on animal models given high intravenous doses, glucosamine/chondroitin (1500 mg/1200 mg daily) does not adversely affect short-term glycemic control for patients whose diabetes is well-controlled, or for those without diabetes or glucose intolerance (SOR: A, consistent, good-quality patient-oriented evidence). Some preliminary evidence suggests that glucosamine may worsen glucose intolerance for patients with untreated or undiagnosed glucose intolerance or diabetes (SOR: C, extrapolation from disease-oriented evidence). Long-term effects are unknown; however, no compelling theoretical or incidental data suggest that long-term results should be different (SOR: C, expert opinion). Further studies are required to clarify the effects of glucosamine on patients with poorly controlled diabetes or glucose intolerance.
- Number of References:
10
- Comments:
Comment in: J Fam Pract. 2007 May;56(5):343. (PMID: 17475162)
- Accession Number:
0 (Blood Glucose)
0 (Glycated Hemoglobin A)
0 (Nonprescription Drugs)
9007-27-6 (Chondroitin)
N08U5BOQ1K (Glucosamine)
- Publication Date:
Date Created: 20061202 Date Completed: 20070206 Latest Revision: 20221207
- Publication Date:
20231215
- Accession Number:
17137550
No Comments.